What should I know about gadobenate dimeglumine before receiving it?

Gadobenate dimeglumine should not be used by people who are allergic to any of the ingredients in this drug, such as gadolinium and benzyl alcohol. It also is contraindicated in people with certain types of kidney disease, because of the risk of nephrogenic systemic fibrosis, a serious condition that causes scarring of the muscles, eyes, skin and internal organs. The most commonly reported side effects associated with gadobenate include: headaches, dizziness, abnormal taste and nausea. You should seek immediate medical attention if you experience joint stiffness, muscle weakness, bone pain in the hips or ribs, yellow eyes, skin changes or symptoms of a life-threatening allergic reaction, such as wheezing, chest tightness, swelling of the face or throat or difficulty breathing.

You should tell your doctor if you have any of the following conditions: risk factors for abnormal heart rhythms (such as heart disease, use of drugs that can affect heart rhythms and chemical imbalances in the blood); asthma or allergies; sickle cell or hemolytic anemia or related blood disorders; liver disease; Dubin-Johnson syndrome; and seizures. These conditions may increase your risk of side effects from gadobenate. The safety of gadobenate has not been determined in children or in pregnant women. If you are nursing an infant, you should wait 24 hours after receiving this drug before resuming breastfeeding.

Continue Learning about Diagnostic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.